Page last updated: 2024-10-30

metformin and Acidosis, Respiratory

metformin has been researched along with Acidosis, Respiratory in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Acidosis, Respiratory: Respiratory retention of carbon dioxide. It may be chronic or acute.

Research Excerpts

ExcerptRelevanceReference
"Thirty (39%) patients suffered cardiac arrest before admission."1.43Prognosis of patients presenting extreme acidosis (pH <7) on admission to intensive care unit. ( Allou, N; Allyn, J; Brulliard, C; Combe, P; Galliot, R; Jabot, J; Martinet, O; Tabatchnik, X; Vandroux, D, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allyn, J1
Vandroux, D1
Jabot, J1
Brulliard, C1
Galliot, R1
Tabatchnik, X1
Combe, P1
Martinet, O1
Allou, N1

Other Studies

1 other study available for metformin and Acidosis, Respiratory

ArticleYear
Prognosis of patients presenting extreme acidosis (pH <7) on admission to intensive care unit.
    Journal of critical care, 2016, Volume: 31, Issue:1

    Topics: Acidosis; Acidosis, Lactic; Acidosis, Respiratory; Adult; Aged; Diabetes Mellitus; Extracorporeal Me

2016